Bliss GVS Pharma Ltd NSE  /  BSE

Pharmaceuticals, Mid Cap

25 Sep 2017 | 03:59 PM

158.40
-1.80 (-1.12%)

  • Outperforms Index

    12.38%

    Return (1Y)

    Beaten S&P BSE Healthcare by 29.98%

  • More Volatile

    2.86%

    Standard Deviation (1Y)

    Higher than S&P BSE Healthcare by 1.77%

  • Consistent Performer

    8/12

    Months

    beaten S&P BSE Healthcare

  • AxisDirect View

    No View

52 Week High-Low

203

202.75

118

117.50

News & Announcements

Price vs Volume

Stock Trivia

  • FII shareholding in Bliss GVS Pharma Ltd has increased by 24.6% since past 3 Months

  • MF shareholding in Bliss GVS Pharma Ltd has increased by 52.09% since past 3 Months

  • FII shareholding in Bliss GVS Pharma Ltd has increased by 59.62% since past 1 Year

  • MF shareholding in Bliss GVS Pharma Ltd has increased by 108.31% since past 1 Year

Loading...